UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000006911
Receipt number	R000008139
Scientific Title	Randomized Phase II study of Bevacizumab with SOX versus Bevacizumab with XELOX as second-line therapy in metastatic colorectal cancer which has prior therapy of S-1 and CPT-11
Date of disclosure of the study information	2011/12/19
Last modified on	2011/12/19 22:57:21

---